Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ff67d26deeca1d359fc239f5e21f0a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fcb093a174d5182b5854b704cb09354 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
filingDate |
2001-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b64532b3bc991296156b24dd67a9c55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8eacb410faa84d8b88f33b06cdcfa78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f95a843ea443c0421ac46207906dde83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_572a63bfbf548ac025a289055d6e7700 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1667752e6687677e99aac97ae28fb1c |
publicationDate |
2007-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2441461-C |
titleOfInvention |
Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
abstract |
Niacin and niacin prodrugs are topically administered as suitable formulations or devices for improving the lipid profiles of subjects, preferably humans. |
priorityDate |
2000-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |